National Health Act 1953 Amendment determination under section 84AH exempt items (No. PB 69 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 69 of 2008

Amendment determination under section 84AH of the National Health Act 1953

I, ANDREW MITCHELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing make this instrument under section 84AH of the National Health Act 1953.

Dated 3 JUNE 2008

ANDREW MITCHELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination – exempt items

1        Commencement

This instrument commences on 1 July 2008.

2           Amendment of PB 58 of 2007

Schedule 1 amends PB 58 of 2007.

Schedule 1   Amendments

[1]     Schedule 1, item dealing with Baclofen

omit from the columns in the order indicated:

Baclofen	Injection 10 mg in 5 mL	Injection
Baclofen	Injection 10 mg in 20 mL	Injection

[2]     Schedule 1, item dealing with Cyclosporin

omit from the columns in the order indicated:

Cyclosporin Solution concentrate for intravenous infusion 250 mg in 5 mL Injection

[3]     Schedule 1, item dealing with Hydrocortisone

omit from the columns in the order indicated:

Hydrocortisone	Injection 100 mg (as sodium succinate)	Injection
Hydrocortisone	Injection 250 mg (as sodium succinate)	Injection

[4]     Schedule 1, after item dealing with Lansoprazole

insert in the columns in the order indicated:

Levodopa with Carbidopa Tablet 200 mg-50 mg (anhydrous) (modified release)  Oral

[5]     Schedule 1, item dealing with Metronidazole

omit from the columns in the order indicated:

Metronidazole Solution for intravenous infusion 500 mg in 100 mL Injection

[6]     Schedule 1, item dealing with Octreotide

omit from the columns in the order indicated:

Octreotide	Injection (modified release) 10 mg (as acetate) vial and diluent syringe	Injection
Octreotide	Injection (modified release) 20 mg (as acetate) vial and diluent syringe	Injection
Octreotide	Injection (modified release) 30 mg (as acetate) vial and diluent syringe	Injection

[7]     Schedule 1, after item dealing with Salbutamol, Oral solution 2 mg

(as sulfate) per 5 mL, 150 mL

insert in the columns in the order indicated:

Salbutamol Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) Inhalation by mouth